| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.29 | 3e-07 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.26 | 0.05 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |